期刊文献+

浆细胞骨髓瘤应用核医学影像诊断的临床价值分析

Clinical Value of Nuclear Medical Imaging in Diagnosis of Plasma Cell Myeloma
下载PDF
导出
摘要 目的探究浆细胞骨髓瘤应用核医学影像诊断的临床价值.方法本研究选取近年来淄博万杰肿瘤医院诊治的浆细胞骨髓瘤患者共120例,随机平均分别两组,即观察组和对照组各60例.观察组使用的是核医学影像诊断的方式.对照组使用的是常规性的影像诊断方式.以上全部接受医学影像检查工作,由资深检查医师完成操作,提升医学诊断的符合率.结果观察组诊断的准确度为100%、灵敏度为93.33%,而对照组患者其准确度和灵敏度分别为90%和80%,数值差异具有显著性(P<0.05).观察组特异性80%明显低于对照组90%(P<0.05).结论核医学影像诊断浆细胞骨髓瘤的临床价值分析中,不仅具有良好的灵敏度和精确性,还可以根据发病的不同类型确定患者不同的阶段,值得推广应用. Objective To explore the clinical value of plasma cell myeloma diagnosed by nuclear medical imaging. Methods 120 patients with plasma cell myeloma diagnosed and treated in this study. The observation group used nuclear medical imaging. The control group used conventional imaging. Results the sensitivity of the test in the observation group was 93.33% compared with 80% in the control group, and the accuracy in the observation group was 100% compared with 90% in the control group. All the patients using nuclear medical technology were significantly better than those using X-ray examination(P<0.05). The specificity of the observation group was 80%, lower than that of the control group(P<0.05). Conclusion Analysis of the clinical value of nuclear medical imaging in the diagnosis of plasma cell myeloma, not only the results were better, but also the accuracy was improved.
作者 宋宝钢 Baogang SONG(Shandong Zibo Wanjie Cancer Hospital,Zibo Shandong 255213,China)
出处 《国际感染病学(电子版)》 CAS 2019年第4期51-52,共2页 Infection International(Electronic Edition)
关键词 核医学影像诊断 骨髓瘤 临床价值 Nuclear medical imaging diagnosis Multiple myeloma Clinical value
  • 相关文献

参考文献5

二级参考文献68

  • 1丁莹莹,高德培,谭静,李鵾.脊柱溶骨性转移瘤的CT诊断[J].实用放射学杂志,2004,20(8):719-721. 被引量:8
  • 2李保灿,黄文起,孔凡之.附件骨MRI表现在脊椎骨髓瘤、转移瘤鉴别中的价值[J].实用放射学杂志,2006,22(3):310-313. 被引量:5
  • 3中国医师协会血液科医师分会,中华医学会血液学分会,中国多发性骨髓瘤工作组.中国多发性骨髓瘤诊治指南(2013年修订).中华内科杂志,2013,52:791-795.
  • 4Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid I: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States[J]. J Clin Oncol, 2008,26( 18): 3063 - 3072.
  • 5Barakat MT, Meeran K, Bloom SR. Neuroendocrine tumours[J]. En- docr Relat Cancer, 2004,11 ( 1 ) : 1 - 18.
  • 6Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors [ J ]. Endocr Rev, 2004,25(3) :458 -511.
  • 7Modlin IM, Lye KD, Kidd M. A 5 -decade analysis of 13,715 carci- noid tumors[ J]. Cancer, 2003,97 (4) :934 - 959.
  • 8Bornschein J, Kidd M, Malfertheiner P, et al. Gastrointestinal neuroen- docrine tumors[J]. Dtsch Med Wochenschr, 2008,133 (28 - 29 ) : 1505 - 1510.
  • 9Nikou GC, Lygidakis N J, Toubanakis C, et al. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin - A, somatostatin receptor scintigra- phy and somatostatin analogues [J]. Hepatogastroenterology, 2005,52 (63) :731 -741.
  • 10Papotti M, Bongiovanni M, Volante M, et al. Expression of somatosta- tin receptor types 1 -5 in 81 cases of gastrointestinal and pancreatic en- docrine tumors. A correlative immunohistochemieal and reverse - tran- scriptase polymerase chain reaction analysis[ J]. Virehows Arch, 2002, 440 ( 5 ) :461 - 475.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部